This Virtual Analyst Day recording, from June 2022, is featuring a presentation by Amir London, Chief Executive Officer, Chaime Orlev, Chief Financial Officer, and Jon R. Knight, Vice President, U.S. Commercial Operations, who are presenting Kamada’s key growth catalysts and the company’s strategic evolution into a fully-integrated specialty plasma company with six FDA-approved products and strong commercial capabilities in the U.S. market, as well as a global commercial footprint in over 30 countries.
